16.08 USD
▲-1.14+4.55%
盘后 15.49 +0.72%
2026-08-03
市值
$1.36B
市盈率
—
EPS
-1.50
股息率
—
52 周区间
4.12 – 25.77
成交量
2.82M
Beta
1.53
目标价
30.67
52W 低 4.1252W 高 25.77
价格走势
公司简介
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1α, IL-1β and IL...